Bavdegalutamide
Bavdegalutamide is an experimental proteolysis targeting chimera that functions as a androgen receptor degrader.[1] It is being developed to treat metastatic castration-resistant prostate cancer.[2][3][4] This drug article relating to the genito-urinary system is a stub.You can help Wikipedia by expanding it.